,Date,Title,URL,Journal,Severe,Severe lower bound,Severe upper bound,Severe p-value,Severe Significant,Severe Adjusted,Severe Calculated,Fatality,Fatality lower bound,Fatality upper bound,Fatality p-value,Fatality Significant,Fatality Adjusted,Fatality Calculated,Multivariate adjustment,Design,Sample,Study population,Added on,Critical only,Discharged vs. death?,Sample Text,Matches,Entry
,2020-08-31,Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers,https://doi.org/10.1016/j.dsx.2020.03.016,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,187.0,"Methods We have systematically searched the medical database up to March 27, 2020 and retrieved all the published articles in English language related to our topic using MeSH key words.",,,,"In a study of 187 patients with COVID-19, Guo et al.","found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p ¼ 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p ¼ 0.09) for death.

found hypertension to have a hazard ratio (HR) of 1.82 (95% CI, 1.13 to 2.95; p = 0.01) for acute respiratory distress syndrome (ARDS) and 1.70 (95% CI, 0.92 to 3.14, p = 0.09) for death.",2020-04-17
,2020-08-31,"Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations",https://doi.org/10.1016/j.dsx.2020.04.004,Diabetes & Metabolic Syndrome: Clinical Research & Reviews,,,,,,,,,,,,,,,,Retrospective observational,161.0,"Methods PubMed database and Google Scholar were searched using the key terms ‘COVID-19’, ‘SARS-CoV-2’, ‘diabetes’, ‘antidiabetic therapy’ up to April 2, 2020.",,,,A study in 161 patients with COVID-19 in Wuhan found increased time for viral clearance in patients with diabetes .,"the odds ratio (OR) of severe COVID-19 was not significantly higher in patients with diabetes (OR, 2.07; 95% CI, 0.89 to 4.82), unlike hypertension (OR, 2.36; 95% CI, 1.46 to 3.83) and CVD (OR, 3.42; 95% CI, 1.88 to 6.22).

found that diabetic patients had a hazard ratio (HR) of 2.34 (95% CI, 1.35 to 4.05; p = 0.002) for acute respiratory syndrome (ARDS).",2020-05-12
,2020-08-01,COVID-19 transmission in Mainland China is associated with temperature and humidity: A time-series analysis,https://doi.org/10.1016/j.scitotenv.2020.138778,Science of The Total Environment,,,,,,,,,,,,,,,,Time-to-event analysis,,"Daily counts of laboratory-confirmed cases in all provinces in China were collected from the official reports of the National Health Commission of People's Republic of China from December 1, 2019 to February 11, 2020 for Hubei province and from January 20, 2020 to February 11, 2020 for other provinces.",,,,"This study sought to examine the associations of daily average temperature (AT) and relative humidity (ARH) with the daily counts of COVID-19 cases in 30 Chinese provinces (in Hubei from December 1, 2019 to February 11, 2020 and in other provinces from January 20, 2020 to Februarys 11, 2020).","The IRRs here were 0.78 (95% CI: 0.69-0.89), 0.84 (95% CI: 0.75-0.93), and 0.89 (95% CI: 0.8-1).",2020-05-12
,2020-05-12,"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic",https://doi.org/10.1016/j.jacc.2020.03.031,Journal of the American College of Cardiology,,,,,,,,,,,,,,,,Retrospective observational,52.0,A retrospective analysis in patients with COVID-19,,,,"In a case series of 52 critically ill patients with COVID-19, 83.3% (5 of 6) of patients who were treated with ECMO did not survive.", demonstrated that patients with acute respiratory infections are at elevated risk for subsequently developing acute MI after influenza (incidence ratio: 6.1; 95% CI: 3.9 to 9.5) and after noninfluenza viral illnesses including other coronavirus species (incidence ratio: 2.8; 95% CI: 1.2 to 6.2).,2020-05-12
,2020-05-07,Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States,https://doi.org/10.1016/j.cell.2020.04.021,Cell,,,,,,,,,,,,,,,,Other,168.0,"Daily COVID-19 cases from international locations were obtained from the European Centre for Disease Prevention and Control via Our World in Data ( International data were accessed on March 19, 2020.",,,,"The COVID-19 Outbreak in Connecticut Is Phylogenetically Linked to SARS-CoV-2 from Washington (A) We constructed a maximum-likelihood tree using 168 global SARS-CoV-2 protein coding sequences, including 9 sequences from COVID-19 patients identified in Connecticut from March 6-14, 2020.", : 0.092 (95% CI = 0.05-0.20).,2020-05-12
,2020-05-06,Impact of policy interventions and social distancing on SARS-CoV-2 transmission in the United States,https://doi.org/10.1101/2020.05.01.20088179,medrxiv,,,,,,,,,,,,,,,,Case series,500.0,"In order to retrospectively analyze metrics of disease spread and mortality, case and death data were compiled up to April 30th, 2020 from the COVID-19 time series made available by The New York Times.",,,,The primary outcomes were average Rt in the week following 500 cases and doubling time from 500 to 1000 cases.,"(ß = -0.15, 95% CI -0.23 to -0.07, p < 0.001, Table 2 ).",2020-05-12
,2020-05-05,Risk Factors of the Severity of COVID-19: A Meta-Analysis,https://doi.org/10.1101/2020.04.30.20086744,medrxiv,,,,,,,,,,,,,,,,Systematic review,2272.0,"Both of the authors searched through PubMed, Google Scholar, EMBASE, and Cochrane Library using keywords:",,,,We have extracted 2272 patients' information from 10 autonomous studies 14-23 and incorporated them into this research.,"We found fever (RR=1.21, 95% CI, 0.66 to 2.22), cough (1.13, 95% CI, 0.98 to 1.30), and diarrhea (RR=1.14, 95% CI, 0.93 to 1.40) as insignificant risk factors for COVID-19 severity.

This study found sex (male) (Risk ratio [RR] =1.29, 95% CI, 1.07 to 1.54), hypertension (RR=1.79, 95% CI, 1.57 to 2.04), diabetes (RR=1.57, 95% CI, 1.25 to 1.98), fatigue or myalgia (RR=1.17, 95% CI, 1.02; 1.35), and smoking history (RR=1.71, 95% CI,1.25; 2.35) are potential risk factors for the severity of COVID-19.",2020-05-12
,2020-05-05,ai-corona: Radiologist-Assistant Deep Learning Framework for COVID-19 Diagnosis in Chest CT Scans,https://doi.org/10.1101/2020.05.04.20082081,medrxiv,,,,,,,,,,,,,,,,Other,2121.0,"Respiratory samples including pharyngeal swabs/washing were obtained from February 20 th till April 3 rd , 2020, from the hospitalized patients.",,,,"Method: Our dataset comprises 2121 cases of axial spiral chest CT scans in three classes; COVID-19 abnormal, non COVID-19 abnormal, and normal, from which 1764 cases were used for training and 357 cases for validation.","ai-corona achieves an AUC score of 0.989 (95% CI: 0.984, 0.994), 0.997 (95% CI: 0.995, 0.999), 0.986 (95% CI: 0.981, 0.991), 0.959 (95% CI: 0.944, 0.974), 0.978 (95% CI: 0.968, 0.988), and 0.961 (95% CI: 0.951, 0.971) in each combination, respectively.",2020-05-12
,2020-05-05,CT manifestations and clinical characteristics of 1115 patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis,https://doi.org/10.1016/j.acra.2020.04.033,Academic Radiology,,,,,,,,,,,,,,,,Systematic review,14.0,"Materials and methods: A systematic literature search of PubMed, EMBASE, the Cochrane Library, and Web of Science was performed to identify studies assessing CT features, clinical and laboratory results of COVID-19 patients.",,,,Results: A total of 14 articles(including 1115 patients) based on chest CT images were retrieved.,"The incidence of fever was 80% (95% CI 74-87%), which served as the most prevalent clinical manifestation, followed by cough (53%, 95% CI 33-72%), and minor symptoms were muscle soreness (21%, 95% CI 15-26%) and diarrhea (7%, 95% CI 4-10%).",2020-05-12
,2020-05-02,Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank,https://doi.org/10.1101/2020.04.28.20083295,medrxiv,,,,,,,,,,,,,,,,Case series,1474.0,March 2020 to 14th April 2020.,,,,"Results were available for 2,724 tests conducted on 1,474 individuals.","  socioeconomic deprivation (RR 1.26 (95% CI 1.14-1.40)), longstanding illness (RR 1.38 (95% CI 1.09-1.74)), lower HDL-cholesterol (RR 0.82 (95% CI 1.72-0.95)) and higher cystatin C (RR 1.24 (95% CI 1.12-1.37)) ( Table 2) .",2020-05-12
,2020-05-01,"Racial, Economic and Health Inequality and COVID-19 Infection in the United States",https://doi.org/10.1101/2020.04.26.20079756,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,1981.0,"Data source: Data sources in this study include, 1) publicly available data from USAfacts and the US Census Bureau for COVID-19 cases and county-level demographic data, 9, 10 2) COVID-19 data reported by each state on their department of health websites, 9 3) State Population by Race/Ethnicity data, 11, 12 and 4) mobility data extracted from Google.",,,,"African Americans were more vulnerable to COVID-19 than other ethnic groups (1,981 African American infected cases versus 658 Whites per million).","CI: -0.41, -0.12, q<0.003).",2020-05-12
,2020-04-29,SARS-CoV-2 and gastrointestinal tract: the dark side of the pandemic,https://doi.org/10.1016/j.dld.2020.04.028,Digestive and Liver Disease,,,,,,,,,,,,,,,,Other,74.0,In December 2019 a novel coronavirus SARS-CoV2 was identified in China .,,,,An interesting study assessed the persistence of the SARS-COV2 fecal expression collecting both respiratory and fecal samples from 74 patients every 1-2 days until two sequential negative results were obtained.,"In a meta-analysis of 60 studies, 4243 patients, the pooled prevalence of all gastrointestinal symptoms was 17.6% (95% CI, 12.3%-24.5%); 11.8% of patients with nonsevere COVID-19 had gastrointestinal symptoms (95% CI, 4.1%-29.1%) and 17.1% of patients with severe COVID-19 had gastrointestinal symptoms (95% CI, 6.9%-36.7%).",2020-05-01
,2020-04-28,Health Insurance Status and Risk Factors for Poor Outcomes With COVID-19 Among U.S. Health Care Workers: A Cross-sectional Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197038/,Ann Intern Med,,,,,,,,,,,,,,,,Cross-sectional,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,,,,Moderate/severe asthma = Had an asthma attack in past 12 mo or had an emergency department visit for asthma in past 12 mo or used more than 3 canisters or disks of inhalers in past 3 mo.,"Of these highrisk persons, 275 000 (CI, 154 000 to 396 000), or 7.5% (CI, 4.2% to 10.8%), were uninsured, including 11.4% (CI, 4.6% to 18.2%) of those with diabetes and 20.8% (CI, 13.8% to 27.8%) of those with chronic lung disease other than asthma.",2020-05-12
,2020-04-26,COVID-19 Epidemic in Algeria: Assessment of the implemented preventive strategy,https://doi.org/10.1101/2020.04.21.20074443,medrxiv,,,,,,,,,,,,,,,,Modeling,15613.0,"We collected data on preventive and control actions, implementation dates and confirmed COVID-19 cases number from official reports of governmental institutions and official media in Algeria (Algerian Ministry of Health, 2020; APS, 2020).",,,,"Our projection revealed that 15613 cases of COVID-19 were avoided in 14 days, from April 6, to April 19, 2020, in the whole country, and 1747 cases were prevented in Blida during the same period.",", the results are R0-befor=1,69 (95% CI 1,49-1,88) and R0-after=1,14 (95% CI 1,10-1,18), the p value was <10 -5 .",2020-05-01
,2020-04-25,COVID-19 Fatality and Comorbidity Risk Factors among Confirmed Patients in Mexico,https://doi.org/10.1101/2020.04.21.20074591,medrxiv,,,,,,,,,,,,,,,,Other,7497.0,"In this paper we estimate fatality risks based on survival analysis methods, calculated from individual-level data on symptomatic patients confirmed with COVID-19 recently released by the Mexican Ministry of Health.",,,,"Our analysis is based on 7,497 patients who tested positive for COVID-19 in Mexico, a subset of a larger dataset of 49,167 patients with COVID-19 related symptoms who sought attention in medical units and were tested with positive, negative (29,301 cases) and pending (12,369 cases) results.","In contrast, high blood pressure increases the estimated hazard by 38% (HR=1.378, 95% CI: 1.086-1.749), immune suppression by 70% (HR=1.696, 95% CI: 1.148-2.505), diabetes by 73% (HR=1.730, 95% CI: 36.0-120.2), COPD by 77% (HR=1.770, 95% CI: 1.269-2.469), obesity by 78% (HR=1.776, 95% CI: 1.415-2.231), and chronic liver disease by 168% (HR=2.679, 95% CI: 1.789-4.014).",2020-05-01
,2020-04-25,Forecasting the Impact of Coronavirus Disease During Delivery Hospitalization: An Aid for Resources Utilization,https://doi.org/10.1016/j.ajogmf.2020.100127,American Journal of Obstetrics & Gynecology MFM,,,,,,,,,,,,,,,,Modeling,860475.0,We generated daily forecast for the reported incidence of COVID-19 in the US from 4/15/2020 -138 12/31/2020 based on the incidence data from 3/1/2020 -4/14/2020.,,,,"33 Results: From 3/1/2020 -12/31/2020, our model forecasted a total of 860,475 cases of COVID-34 19 in general population across the United States.","Among those, 3,308 (95% CI, 1,755 – 4,861) cases are expected to be severe, 681 (95% CI, 1324 – 1,038) critical and 52 (95% CI, 23 – 81) maternal mortality.

36 Among those, 3,308 (95% CI, 1,755 -4,861) cases are expected to be severe, 681 (95% CI, 1324 37 -1,038) critical and 52 (95% CI, 23 -81) maternal mortality.",2020-05-01
,2020-04-22,Coronavirus Disease (COVID-19) Pandemic: An Overview of Systematic Reviews,https://doi.org/10.1101/2020.04.16.20068213,medrxiv,,,,,,,,,,,,,,,,Systematic review,1063.0,"Methods: Nine databases (Medline, EMBASE, Cochrane Library, CINAHL, Web of Sciences, PDQ-Evidence, WHO's Global Research, LILACS and Epistemonikos) were searched from December 1, 2019 to March 24, 2020.",,,,"Our search retrieved 1,063 publications, of which 175 were duplicates.","There was a higher likelihood that patients with severe disease had hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory disease (OR 2.46, 95% CI: 1.76-3.44), or cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22), compared with patients with non-severe disease.

The most common comorbidities were hypertension (17±7, 95% CI 14-22%), diabetes (8±6, 95% CI 6-11%), cardiovascular diseases (5±4, 95% CI 4-7%) and respiratory system diseases (2±0, 95% CI 1-3%).

The most common clinical symptoms were fever (91±3%, 95% CI 86-97%), cough (67±7%, 95% CI 59-76%), fatigue (51±0%, 95% CI 34-68%) and dyspnea (30±4%, 95% CI 21-40%).

Clinical symptoms presented were fever (88.7%, 95% CI 84.5-92.9%), cough (57.6%, 95% CI 40.8-74.4%) and dyspnea (45.6%, 95% CI 10.9-80.4%).

The incidence of symptoms were shown as following: Fever 82%, (CI) 56%-99%; Cough 61%, 95% CI 39%-81%; Muscle aches and/or fatigue 36%, 95% CI 18%-55%; Dyspnea 26%, 95% CI 12%-41%; Headache 12%, 95% CI 4%-23%; Sore throat 10%, 95% CI 5%-17% and gastrointestinal symptoms 9%,95% CI 3%-17%.

ARDS incidence was 0.148 (95% CI: 0.046-0.296)",2020-05-01
,2020-04-22,Effectiveness and Safety of Glucocorticoids to Treat COVID-19: A Rapid Review and Meta-Analysis,https://doi.org/10.1101/2020.04.17.20064469,medrxiv,,,,,,,,,,,,,,,,Systematic review,17.0,World Health Organization 2020,,,,"One study included adult patients with severe MERS, 17 studies included patients with SARS, and the remaining five studies were on patients with COVID-19 (Table 1) .","(WMD=0.95 days, 95% CI: -7.57 to 9.48, I²=94.6%).",2020-05-01
,2020-04-17,Clinical Characteristics of Children with COVID-19: A Rapid Review and Meta-Analysis,https://doi.org/10.1101/2020.04.13.20064352,medrxiv,,,,,,,,,,,,,,,,Systematic review,49.0,"Methods: We searched studies reporting clinical characteristics in children with COVID-19 published until March 31, 2020.",,,,"Results: Our search retrieved 49 studies, including 25 case reports, 23 case series and one cohort study, with a total of 1667 patients.","The main symptoms of children were fever (48%, 95% confidence interval [CI]: 39%, 56%) and cough (39%, 95% CI: 30%, 48%).",2020-04-24
,2020-04-17,Flattening-the-curve associated with reduced COVID-19 case fatality rates- an ecological analysis of 65 countries,https://doi.org/10.1016/j.jinf.2020.04.007,Journal of Infection,,,,,,,,,,,,,,,,Case series,,Dramatic interventions to increase hospital capacity in Wuhan were associated with a subsequent decline in the case fatality rate in this city.,,,,The most recent data available as of 29 March 2020 was used.,"−0.003, 95% CI −0.004-−0.002; Table 1 ).",2020-05-01
,2020-04-16,Cardiovascular Diseases and COVID-19 Mortality and Intensive Care Unit Admission: A Systematic Review and Meta-analysis,https://doi.org/10.1101/2020.04.12.20062869,medrxiv,,,,,,,,,,,,,,,,Systematic review,3473.0,"Searched Databases included PubMed, Embase, Scopus, Web of Science, Cochrane Library, medRxiv pre-print database as well as Science Direct search engine.",,,,Results: Sixteen papers including 3473 patients entered into meta-analysis for ICU admission and mortality outcome and fifty-nine papers including 9509 patients for descriptive outcomes.,"Results of meta-analysis indicated that acute cardiac injury, (OR: 15.94, 95% CI 2.31-110.14), hypertension (OR: 1.92, 95% CI 1.92-2.74), heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.

Results of meta-analysis indicated that acute cardiac injury (OR: 15.94, 95% CI 2.31-110.14), Hypertension (OR: 1.92, 95% CI 1.92-2.74), Heart Failure (OR: 11.73, 95% CI 5.17-26.60), other cardiovascular disease (OR: 1.95, 95% CI 1.17-3.24) and overall CVDs (OR: 3.37, 95% CI 2.06-5.52) were significantly associated with mortality in COVID-19 patients.",2020-04-24
,2020-04-13,"Nosocomial infection among patients with COVID-19: A retrospective data analysis of 918 cases from a single center in Wuhan, China",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180328/,PMC,,,,,,,,,,,,,,,,Retrospective observational,918.0,"We retrospectively analyzed the clinical data of 918 COVID-19 patients in Tongji Hospital from December 30, 2019, to February 29, 2020.",,,,"We retrospectively analyzed the clinical data of 918 COVID-19 patients in Tongji Hospital from December 30, 2019, to February 29, 2020.","Among these factors, the highest odds ratio was for invasive devices (OR, 4.62; 95% CI, 2.47–8.62) followed by diabetes (OR, 3.04; 95% CI, 1.38–6.69), combination of antibiotics (OR, 3.02; 95% CI, 1.10–8.26), glucocorticoid treatment (OR, 2.44; 95% CI, 1.36–4.37), and hematological disease (OR, 1.95; 95% CI, 1.01–1.06).",2020-05-01
,2020-04-11,"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City",https://doi.org/10.1101/2020.04.08.20057794,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,4103.0,"Methods: We conducted a cross-sectional analysis of all patients with laboratory-confirmed Covid-19 treated at a single academic health system in New York City between March 1, 2020 and April 2, 2020, with follow up through April 7, 2020.",,,,"Results: Among 4,103 Covid-19 patients, 1,999 (48.7%) were hospitalized, of whom 981/1,999 (49.1%) have been discharged home, and 292/1,999 (14.6%) have died or were discharged to hospice.","Strongest hospitalization risks were age ≥75 years (OR 66.8, 95% CI, 44.7-102.6), age 65-74 (OR 10.9, 95% CI, 8.35-14.34), BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and heart failure (OR 4.3 95% CI, 1.9-11.2).

In multivariable analysis, the factors most associated with hospitalization were age 75 years or older (OR 66.8, 95% CI, 44.7 to 102.6), age 65-74 (OR 10.9, 95% CI, 8.35 to 14.34), 1 1 BMI>40 (OR 6.2, 95% CI, 4.2-9.3), and history of heart failure (OR 4.3 95% CI, 1.9-11.2).",2020-04-17
,2020-04-10,The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis,https://doi.org/10.1101/2020.04.08.20057539,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,30.0,"DESIGN, SETTING, AND PARTICIPANTS Multicenter, retrospective cohort study of 564 consecutively hospitalized patients with confirmed COVID-19 at Third Xiangya Hospital of Central South University, Changsha Public Health Treatment Center, First Hospital of Yueyang, Junshan People's Hospital of Yueyang, Central Hospital of Shaoyang, Central Hospital of Xiangtan, Second Hospital of Changde, Central Hospital of Loudi, and First Affiliated Hospital of University of South China in Hunan province from January 17, 2020 to February 28, 2020; The final date of follow-up was March 15, 2020.",,,,"Thirty patients were classified with severe pneumonia on admission and were excluded, to leave 534 patients with non-severe COVID-19 on admission for further analysis.","95% CI, -10 to -7; P < 0.001).",2020-04-17
,2020-04-10,COVID-19 UK Lockdown Forecasts and R0,https://doi.org/10.1101/2020.04.07.20052340,medrxiv,,,,,,,,,,,,,,,,Modeling,500.0,A time series of reported COVID-19 cases and deaths in the UK is available from Public Health England.,,,,"For Figure 3 , using the 20% lockdown, 500 samples were drawn for (b1, b2, b3).","R0 = 5.81 with 90% CI (5.08 , 6.98).",2020-04-17
,2020-04-08,A model to predict SARS-CoV-2 infection based on the first three-month surveillance data in Brazil.,https://doi.org/10.1101/2020.04.05.20047944,medrxiv,,,,,,,,,,,,,,,,Case series,1468.0,We included the patients reported between 11/01/2020 and 25/03/2020.,,,,Results: We described 1468 COVID-19 cases (confirmed by RT-PCR) and 4271 patients with other illnesses.,Variable Kidney disease OR (95% CI) 0.06 (0 - 1.06) p value 0.06,2020-04-17
,2020-04-06,Widespread use of face masks in public may slow the spread of SARS CoV-2: an ecological study,https://doi.org/10.1101/2020.03.31.20048652,medrxiv,,,,,,,,,,,,,,,,Systematic review,500.0,Countries with missing data were dropped from the analyses.,,,,"Secondly, we only included countries 155 with at least 500 cumulative cases and countries whose first case was reported 156 before 7 March 2020.","0.07, 95% CI 0.05-0.08, P<0.001).

-326, 95% CI -601- -51, P=0.021).",2020-04-10
,2020-04-03,Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis,https://doi.org/10.1053/j.gastro.2020.03.065,Gastroenterology,,,,,,,,,,,,,,,,Systematic review,59.0,"Methods We collected data from the cohort of patients with COVID-19 in Hong Kong (n=59; diagnosis from February 2 through Feb 29, 2020), and searched PubMed, Embase, Cochrane and three Chinese databases through March 11, 2020 according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.",,,,We included a cohort of 59 patients with virologically confirmed COVID-19 diagnosed between 2 nd and 29 th February 2020 in Hong Kong.,"The pooled prevalence of all gastrointestinal symptoms was 17.1% (95% CI: 6.9-36.7) and 11.8% (95% CI: 4.1-29.1) in patients with severe and non-severe disease, respectively (Figure 4) .

In a meta-analysis of 60 studies, comprising 4243 patients, the pooled prevalence of all gastrointestinal symptoms was 17.6% (95% CI, 12.3%–24.5%); 11.8% of patients with non-severe COVID-19 had gastrointestinal symptoms (95% CI, 4.1%–29.1%) and 17.1% of patients with severe COVID-19 had gastrointestinal symptoms (95% CI, 6.9%–36.7%).",2020-05-12
,2020-04-01,Forecasting the CoViD19 Diffusion in Italy and the Related Occupancy of Intensive Care Units,https://doi.org/10.1101/2020.03.30.20047894,medrxiv,,,,,,,,,,,,,,,,Modeling,6355.0,"This paper employs the data related to COVID-19, collected and regularly updated by the Italian National Institute of Health (an agency of the Italian Ministry of Health) and by the Italian Civil Protection Department.",,,,"• The remaining southern regions (Abruzzo, Molise, Puglia, Basilicata, Calabria, Sicily and Sardinia) will show an upward trend in the number of future positive cases lasting until 6 April, where 6355 cases are predicted.",", 10) and CI * U (h = 2, .",2020-04-10
,2020-03-30,Clinical and Paraclinical Characteristics of COVID-19 patients: A systematic review and meta-analysis,https://doi.org/10.1101/2020.03.26.20044057,medrxiv,,,,,,,,,,,,,,,,Systematic review,49504.0,"We searched databases of Web of Science, Scopus, and PubMed without any time limitation for publications up to March 13, 2020.",,,,"Out of selected papers, a total of 49504 patients infected with CoVID-19 with age ranged between 40 to 58 years old were included in our investigation.","Overall prevalence of these symptoms was 24% (95% CI, 13-34), 19% (95% CI, 11-27), 27% (95% CI, 12-42), 31% (95% CI, 14-48), 6% (95% CI, 2-9), 1% (95% CI, 0-2) and 6% (95% CI, 3-8) (Supplementary File and Table 2 ).

Meta-analysis findings are as follows respectively: 84% (95% CI, 79-88), 65% (95% CI, 59-71), and 14% (95% CI 8-19) ( Fig.

Pooling results were 26% (95% CI, 14-39), 24% (95% CI, 1-48), 4% (95% CI 1-6), 2% (95% CI, 0-3), and 39% (95% CI, 27-51) (Supplementary File and Table 2 ).",2020-04-03
,2020-03-30,Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up,https://doi.org/10.1016/j.jinf.2020.03.019,Journal of Infection,,,,,,,,,,,,,,,,Retrospective observational,339.0,"Methods Consecutive cases over 60 years old with COVID-19 in Renmin Hospital of Wuhan University from Jan 1 to Feb 6, 2020 were included.",,,,"Results 339 patients with COVID-19 (aged 71±8 years,173 females (51%)) were enrolled, including 80 (23.6%) critical, 159 severe (46.9%) and 100 moderate (29.5%) cases.","Symptoms of dyspnea (HR 2.35, CI 1.43-3.87, P = 0.001) and comorbidities including cardiovascular disease (HR 2.87, CI 1.70-4.83, P < 0.001), cerebrovascular disease (HR 3.26, CI 1.66-6.40, P = 0.001) and COPD (HR 3.72, CI 1.94-7.13, P < 0.001) were all predictive of fatal outcomes.",2020-04-17
,2020-03-30,"Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.25.20043133,medrxiv,,,,,,,,,,,,,,,,Systematic review,182.0,"Methods Available data from PubMed, Web of Science, China National Knowledge Infrastructure Database, WanFang Database and VIP Database, were analyzed using a fixed effects model meta-analysis to derive overall odds ratios (OR) with 95% CIs.",,,,"182 studies were retrieved, and 9 studies were finally included after selection.","There were significant correlations between COVID-19 severity and hypertension [OR=2.3 [95% CI (1.76, 3.00), P<0.01], diabetes [OR=2.67, 95% CI (1.91, 3.74), P<0.01], coronary heart disease [OR=2.85 [95% CI (1.68, 4.84), P<0.01].",2020-04-03
,2020-03-27,"A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China",https://doi.org/10.1101/2020.03.24.20042119,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,393.0,"Methods: Patients enrolled in this study were all hospitalized with COVID-19 in the Central Hospital of Wuhan, China.",,,,"Between January 1 and February 28, 2020, a total of 393 patients with COVID-19 were enrolled, but only 377 eligible participants were finally included in our analysis.","The independent risk factors for severe pneumonia were age [odds ratio (OR): 1.059, 95% confidence interval (CI): 1.036-1.082; p < 0.001], N/L (OR: 1.322, 95% CI: 1.180-1.481; p < 0.001), CRP (OR: 1.231, 95% CI: 1.129-1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013-1.107; p = 0.011).

1.036-1.082; p < 0.001], N/L (OR: 1.322, 95% CI: 1.180-1.481; p < 0.001), CRP (OR: 1.231, 95% CI: 1.129-1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013-1.107l p = 0.001) ( Table 2) .",2020-04-03
,2020-03-27,Radiographic Findings and other Predictors in Adults with Covid-19,https://doi.org/10.1101/2020.03.23.20041673,medrxiv,,,,,,,,,,,,,,,,Retrospective observational,128.0,"We retrospectively reviewed records of all laboratory-confirmed patients admitted to a quarantine unit at Tongji Hospital, a large regional hospital in Wuhan, China, between January 31 and March 5, 2020.",,,,A total of 128 patients were admitted.,Univariable OR (95% CI) p value OR (95% CI),2020-04-03
,2020-03-27,History of Coronary Heart Disease Increases the Mortality Rate of Coronavirus Disease 2019 (COVID-19) Patients: A Nested Case-Control Study Based on Publicly Reported Confirmed Cases in Mainland China,https://doi.org/10.1101/2020.03.23.20041848,medrxiv,,,,,,,,,,,,,,,,Case series,146.0,We routinely searched for daily news and public health reports on confirmed COVID-19 cases in all areas in mainland China outside of Hubei Province.,,,,"A total of 321 publicly reported confirmed cases (146 cases and 175 controls) with trackable time-to-death information and history of comorbidities were collected between December 18th, 2019 and March 8th, 2020.",OR (95% CI) P Value OR (95% CI) Multivariate P Value OR (95% CI) P Value,2020-04-10
,2020-03-26,"COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis",https://doi.org/10.1101/2020.03.24.20042903,medrxiv,,,,,,,,,,,,,,,,Systematic review,4789.0,"Methods: We reviewed the scientific literature published from January 1, 2019 to March 3, 2020.",,,,A total of 4789 patients with a mean age of 49 years were evaluated.,"The most common comorbidities were respectively hypertension (18.5 %, CI 12.7-24.4), 246 cardiovascular diseases (14.9 %, CI 6.0-23.8), diabetes (10.8 %, CI 8.3-13.3), chronic liver 247 disease (8.1, CI 4.6-11.6) and smoking (8.0%, CI 2.3-13.6) ( Table 3) .

Fever (83.0%, CI 77.5 to 87.6), cough (65.2%, CI 58.6 to 71.2) and myalgia/fatigue (34.7, CI 26.0 to 44.4) were the most common symptoms.

The most prevalent comorbidities were hypertension (18.5 %, CI 12.7 to 24.4) and Cardiovascular disease (14.9 %, CI 6.0 to 23.8).

The most prevalent comorbidities in our study were hypertension (18.5 %, CI 12.7-24.4) followed 307 by cardiovascular diseases (14.9 %, CI 6.0-23.8) and diabetes (10.8 %, CI 8.3-13.3).",2020-04-03
,2020-03-24,Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096724/,Arch Acad Emerg Med,,,,,,,,,,,,,,,,Systematic review,76993.0,"METHODS: A comprehensive systematic search was performed on PubMed, Scopus, Web of science, and Google scholar, to find articles published until 15 February 2020.",,,,RESULTS: The data of 76993 patients presented in 10 articles were included in this study.,"As shown in figure 6, the pooled prevalence of acute kidney diseases in SARS-CoV-2 hospitalized patients was estimated as 0.83% (95% CI: 0.37%- 1.43%).

As shown in figure 6 , the pooled prevalence of acute kidney diseases in SARS-CoV-2 hospitalized patients was estimated as 0.83% (95% CI: 0.37%-1.43%).",2020-04-03
,2020-03-23,Chinese and Italian COVID-19 outbreaks can be correctly described by a modified SIRD model,https://doi.org/10.1101/2020.03.19.20039388,medrxiv,,,,,,,,,,,,,,,,Other,30000.0,"However, the data reported in for the Italian case are retrieved from , making the use of both the databases interchangeable.",,,,"This caused many deaths in Italy (>20,000) and many other are expected, overcoming 30,000 cases.",of 7.09 (90% CI: 5.84-8.35).,2020-05-01
,2020-03-23,Insignificant effect of counter measure for coronavirus infectious disease -19 in Japan,https://doi.org/10.1101/2020.03.19.20037945,medrxiv,,,,,,,,,,,,,,,,Modeling,1516.0,"Background: To control COVID−19 outbreak in Japan, sports and entertainment events were canceled in Japan for two weeks from 26 February to 13 March.",,,,"During this period, 1516 cases were recorded with onset dates.","99; its 95% CI was [1.71,2.23].",2020-05-01
,2020-03-20,"Incidence, clinical characteristics and prognostic factor of patients with COVID-19: a systematic review and meta-analysis",https://doi.org/10.1101/2020.03.17.20037572,medrxiv,,,,,,,,,,,,,,,,Systematic review,30.0,"Methods: The PubMed, Web of Science Core Collection, Embase, Cochrane and MedRxiv databases were searched through February 25, 2020.",,,,"Results: A total of 30 studies including 53000 patients with COVID-19 were included in this study, the mean age was 49.8 years (95% CI, 47.5-52.2 yrs) and 55.5% were male.","Fever (79.1%; 95% CI, 68.0-90.3%), cough (58.0%; 95% CI, 42.0-74.0%) and fatigue (29.3%; 95% CI, 23.

The predictor for disease severity included old age (≥ 50 yrs, odds ratio [OR] = 2.61; 95% CI, 2.29-2.98), male (OR =1.348, 95% CI, 1.195-1.521), smoking (OR =1.734, 95% CI, 1.146-2.626) and any comorbidity (OR = 2.635, 95% CI, 2.098-3.309), especially chronic kidney disease (CKD, OR = 6.017; 95% CI, 2.192-16.514), chronic obstructive pulmonary disease (COPD, OR = 5.323; 95% CI, 2.613-10.847) and cerebrovascular disease (OR = 3.219; 95% CI, 1.486-6.972).

[95% CI, 4.6-7.3%] vs. 0.1%; [95% CI, 0-0.2%], P < 0.001).

Comorbidities with pooled OR larger than 2 included CKD (6.02; 95% CI, 2.19-16.51; n = 4; I 2 = 0), COPD (5.32; 95% CI, ; n = 6; I 2 = 0%), cerebrovascular diseases (3.19 ; 95% CI, 1.51-6.77; n = 6; I 2 = 0%), tumor (3.21; 95% CI, ; n = 4; I 2 = 30%), diabetes (2.49; 95% CI, ; n = 10; I 2 = 44%) and hypertension (2.06; 95% CI, 1.61-2.62; n = 10; I 2 = 36%) ( Figure 4 , eFigure 5).

In support, COVID-19 related death was associated with old age ( ≥ 60 yrs, RR = 9.45; 95% CI, 8.09-11.04), male (RR = 1.67, 95% CI, 1.47-1.89) and any comorbidity (5.86; 95% CI, ), most notably CVD (6.75; 95% CI, 5.40-8.43) followed by hypertension (4.48; 95% CI, ) and diabetes (4.43; 95% CI, ).

Meanwhile, old age (≥ 60 yrs, RR = 9.45; 95% CI, 8.09-11.04), followed by cardiovascular disease (RR = 6.75; 95% CI, 5.40-8.43) hypertension (RR = 4.48; 95% CI, 3.69-5.45) and diabetes (RR = 4.43; 95% CI, 3.49-5.61) were found to be independent prognostic factors for the COVID-19 related death.

The pooled incidence of severity and mortality were 20.2% (95% CI, 15.1-25.2%) and 3.1% (95% CI, 1.9-4.2%), respectively.

comorbidity (OR = 2.635; 95% CI, 2.098-3.309; n = 7; I 2 = 12%).

The most common comorbidities were hypertension (19.0%, 95% CI, 13.2-24.9%), followed by diabetes (8.2%, 95% CI, 6.3-10.0%) and cardiovascular diseases (CVD, 2.7%, 95% CI, 1.4-4.1%).",2020-03-27
,2020-03-16,Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection,https://doi.org/10.1101/2020.03.15.20035360,medrxiv,,,,,,,,,,,,,,,,Systematic review,2259.0,"All included studies were retrospective cohort studies in design, conducted between December 2019 and February 2020 in China, during the novel coronavirus (SARS-2-CoV) outbreak.",,,,"Results Of the 2259 studies identified, 42 were selected after title and abstract analysis, and 7 studies (including 1813 COVID−19 patients) were chosen for inclusion.","Dyspnoea was the only significant symptom predictive for both severe disease (pOR 3.70, 95% CI 1.83 − 7.46) and ICU admission (pOR 6.55, 95% CI 4.28 − 10.0).",2020-03-27
,2020-03-16,"Preliminary evaluation of voluntary event cancellation as a countermeasure against the COVID-19 outbreak in Japan as of 11 March, 2020",https://doi.org/10.1101/2020.03.12.20035220,medrxiv,,,,,,,,,,,,,,,,Modeling,412.0,"We used data of the community outbreak of patients with COVID-19 who showed any symptom in Japan for 14 January -8 March, 2020.",,,,"During 14 January -8 March in Japan, 412 community-acquired cases were identified for whom the onset date was published.","88; its 95% CI was [1.68,2.02].",2020-03-27
,2020-03-12,Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis,https://doi.org/10.1016/j.ijid.2020.03.017,Int J Infect Dis,,,,,,,,,,,,,,,,Systematic review,576.0,"A systematic search was conducted on studies published from January 1, 2019 to February 25, 2020 in PubMed, EMBASE, and Web of Science databases.",,,,"As of February 25, 2020, a total of 1 576 participants were included in our meta-analysis.","Higher risk of hypertension (OR 2.36, 95% CI: 1.46–3.83), respiratory system disease (OR 2.46, 95% CI: 1.76–3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88–6.22) were observed in the severe group.

Higher risk of hypertension (OR 2.36, 95% CI: 1.46-3.83), respiratory system disease (OR 2.46, 95% CI: 1.76-3.44), and cardiovascular disease (OR 3.42, 95% CI: 1.88-6.22) were observed in the severe group.

When compared between severe and non-severe patients, the pooled OR of hypertension, respiratory system disease, and cardiovascular disease were 2.36 (95% CI: 1.46–3.83), 2.46 (95% CI: 1.76–3.44) and 3.42 (95% CI: 1.88–6.22) respectively.

The most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0–27.2%) and diabetes (9.7%, 95% CI: 7.2–12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8–13.8%) and respiratory system disease (1.5%, 95% CI: 0.9–2.1%).

As shown in Figure 2 (inserts A, B, C, D), the most prevalent comorbidities were hypertension (21.1%, 95% CI: 13.0-27.2%) and diabetes (9.7%, 95% CI: 7.2-12.2%), followed by cardiovascular disease (8.4%, 95% CI: 3.8-13.8%) and respiratory system disease (1.5%, 95% CI: 0.9-2.1%).

The results showed the most prevalent clinical symptom was fever (91.3%, 95% CI: 86–97%), followed by cough (67.7%, 95% CI: 59–76%), fatigue (51.0%, 95% CI: 34–68%) and dyspnea (30.4%, 95% CI: 21–40%).

The results of this meta-analysis showed the most prevalent clinical symptom was fever (91.3%, 95% CI: 86–97%), followed by cough (67.7%, 95% CI: 59–76%), fatigue (51.0%, 95% CI: 34–68%) and dyspnea (30.4%, 95% CI: 21–40%).

The results of this meta-analysis showed the most prevalent clinical symptom was fever (91.3%, 95% CI: 86-97%), followed by cough (67.7%, 95% CI: 59-76%), fatigue (51.0%, 95% CI: 34-68%) and dyspnea (30.4%, 95% CI: 21-40%).",2020-05-12
,2020-03-06,ddPCR: a more sensitive and accurate tool for SARS-CoV-2 detection in low viral load specimens,https://doi.org/10.1101/2020.02.29.20029439,medrxiv,,,,,,,,,,,,,,,,Other,57.0,"To perform the tests of clinical samples, throat swab samples of 63 suspected outpatients and 14 supposed convalescents were randomly collected by the medical staffs from COVID-19 designated Renmin and Zhongnan Hospital of Wuhan University.",,,,"Among 57 samples, all of which were reported as negative nucleic acid by officially approved clinical RT-PCR detection, 43 samples were collected from suspected patients with fever in clinic, and 14 were from supposed convalescents who were about to discharge after treatment.","The sensitivity, specificity, PPV, NPV, NLR and accuracy were improved from 40% (95% CI: 27-55%), 100% (95% CI: 54-100%), 100%, 16% (95% CI: 13-19%), 0.6 (95% CI: 0.48-0.75) and 47% (95% CI: 33-60%) for RT-PCR to 94% (95% CI: 83-99%), 100% (95% CI: 48-100%), 100%, 63% (95% CI: 36-83%), 0.06 (95% CI: 0.02-0.18) and 95% (95% CI: 84-99%) for ddPCR, respectively.",2020-05-12
,2020-02-28,Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease,https://doi.org/10.1097/cm9.0000000000000775,Chin Med J (Engl),,,,,,,,,,,,,,,,Other,11.0,"Patients included in the study had been diagnosed with COVID-19 associated pneumonia between December 30, 2019, and January 15, 2020 , and hospitalized at one of three tertiary hospitals in Wuhan for over two weeks.",,,,"A total of 11 patients (14.1%) were included in the progression group, and 67 patients (85.9%) were included in the improvement/stabilization group.","The results of univariate logistic analysis found that age (OR, 10.575; 95% CI: 2.095–53.386; P = 0.004), history of smoking (OR, 12.187; 95% CI: 1.762–84.306; P = 0.011), maximum body temperature at admission (OR, 9.709; 95% CI: 1.176–83.330; P = 0.035), respiratory failure (OR, 8.021; 95% CI: 2.022–31.821; P = 0.003), severe illness (OR, 4.651; 95% CI: 0.930–23.250; P = 0.061), albumin (OR, 12.536; 95% CI: 2.409–65.233; P = 0.003), creatinine (OR, 6.800; 95% CI: 1.424–32.470; P = 0.016), procalcitonin (OR, 3.831; 95% CI: 0.551–27.027; P = 0.071), C-reactive protein (OR, 5.988; 95% CI: 1.179–30.300; P = 0.031) were significantly associated with the disease progression.

Multivariate logistic analysis indicated that age (odds ratio [OR], 8.546; 95% confidence interval [CI]: 1.628–44.864; P = 0.011), history of smoking (OR, 14.285; 95% CI: 1.577–25.000; P = 0.018), maximum body temperature at admission (OR, 8.999; 95% CI: 1.036–78.147, P = 0.046), respiratory failure (OR, 8.772, 95% CI: 1.942–40.000; P = 0.016), albumin (OR, 7.353, 95% CI: 1.098–50.000; P = 0.003), and C-reactive protein (OR, 10.530; 95% CI: 1.224−34.701, P = 0.028) were risk factors for disease progression.

Furthermore, the multivariate logistic analysis indicated that age (OR, 8.546; 95% CI: 1.628–44.864; P = 0.011), history of smoking (OR, 14.285; 95% CI: 1.577–25.000; P = 0.018), maximum body temperature at admission (OR, 8.999; 95% CI: 1.036–78.147, P = 0.046), respiratory failure (OR, 8.772, 95% CI: 1.942–40.000; P = 0.016), albumin (OR, 7.353, 95% CI: 1.098–50.000; P = 0.003) and C-reactive protein (OR, 10.53; 95% CI: 1.224–34.701, P = 0.028) were risk factors for disease progression [Table 4].",2020-05-12
,2020-02-20,"Psychological responses, behavioral changes and public perceptions during the early phase of the COVID-19 outbreak in China: a population based cross-sectional survey",https://doi.org/10.1101/2020.02.18.20024448,medrxiv,,,,,,,,,,,,,,,,Cross-sectional,112.0,Transmissibility compared with SARS Wuhan Shanghai <0.001,,,,3 The total number of respondents was 398 in the Wuhan sample and 403 in the Shanghai sample because 112 Wuhan participants and 98 Shanghai participants refused to answer.,N (%) N (%) OR (95% CI) Reported all recommended OR (95% CI),2020-03-27
,2020-02-17,Clinical Characteristics of 2019 Novel Infected Coronavirus Pneumonia：A Systemic Review and Meta-analysis,https://doi.org/10.1101/2020.02.14.20021535,medrxiv,,,,,,,,,,,,,,,,Systematic review,9.0,"Methods: Literature have been systematically performed a search on PubMed, Embase, Web of Science, GreyNet International, and The Cochrane Library from inception up to February 8, 2020.",,,,"Results: A total of nine studies including 356 patients were included in this study, the mean age was 52.4 years and 221 (62.1%) were male.","The pooled incidences rate of symptoms as follows: pharyngalgia (12.2%, 95% CI: 0.087-0.167), diarrhea (9.2%, 95% CI: 0.062-0.133) and headache (8.9%, 95% CI: 0.063-0.125).",2020-03-27
,2020-02-11,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated",https://doi.org/10.1101/2020.02.07.20021154,medrxiv,,,,,,,,,,,,,,,,Modeling,,We extracted daily travel data from Wuhan to each of the provinces.,,,,Patients reported in the Li et al.,1F ; CI: 8.7 to 14.9 days).,2020-03-27
,2020-02-09,"The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated",https://doi.org/,ArXiv,,,,,,,,,,,,,,,,Modeling,2.0,We extracted daily travel data from Wuhan to each of the provinces.,,,,"For each parameter set, we generate 2 13 = 8192 Monte Carlo samples.",1F ; CI: 8.7 to 14.9 days).,2020-05-01
0,2020-04-23,Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis,https://doi.org/10.1016/j.jinf.2020.04.021,Journal of Infection,OR 5.15,2.51,10.57,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,3030 patients from 13 studies,China,5/6/2020,Y,N,,,
1,2020-04-15,"Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China [Clinical Microbiology and Infection]",https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(20)30217-2/pdf,Clinical Microbiology and Infection,OR 1.9,0.99,3.64,0.05,Not Significant,Not Adjusted,Calculated,OR 3.22,1.15,8.97,0.03,Significant,Not Adjusted,Calculated,,Retrospective observational study,663,"Renmin Hospital of Wuhan University from January 11th to February 6th, 2020",5/6/2020,N,N,,,
2,2020-03-30,"Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, China",https://doi.org/10.1101/2020.03.25.20037721,medRxiv,OR 3.57,1.31,9.78,0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,323,"Tianyou Hospital from January 8 to February 20, 2020",4/10/2020,N,N,,,
3,2020-03-05,Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis,https://www.ncbi.nlm.nih.gov/pubmed/32173574,International Journal of Infectious Diseases,OR 2.46,1.76,3.44,,Significant,Not Adjusted,Extracted,,,,,,,,,Systematic review and meta-analysis,4 studies enrolling 1145 subjects,"PubMed, EMBASE, and Web of Science published between Jan 1 and Feb 25 2020",4/10/2020,N,N,,,
4,2020-03-03,Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality China: a retrospective descriptive multiple-center study,https://doi.org/10.1101/2020.03.01.20029397,medRxiv,OR 3.37,1.41,8.03,<0.01,Significant,Not Adjusted,Calculated,,,,,,,,,Retrospective observational study,267,"Qianjiang central hospital of Chongqing, Chongqing three gorges central hospital and Chongqing public health medical center from January 19 to February 16, 2025",5/6/2020,N,N,,,
